Reviewers winnowed an initial 27 assays to a group of nine that were evaluated using NCI sample sets, ultimately choosing ClearNote's Avantect and Guardant's Shield.

UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other diseases through a droplet-size saliva sample.

The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.